Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Positive Impact of Blue Light Cystoscopy on Recurrence in Bladder Cancer Presented at the Annual SUO Meeting
Photocure ASA, The Bladder Cancer Company, announces that new evidence was presented at the 22nd […]
JelloX Biotech Leads Research in 3D Cancer Pathology as NCI Explores Potential
JelloX Biotech is celebrating a robust year of research and product development milestones while showcasing […]
Tampa General Hospital's Cancer Institute Awarded Coveted Accreditation from Commission on Cancer
Tampa General Hospital (TGH), the primary teaching hospital for the USF Health Morsani College of […]
Tevogen Bio to Develop T Cell Therapies for Treatment of Epstein-Barr Virus Related Cancers and Multiple Sclerosis
Tevogen Bio, a late-stage clinical biotechnology company specializing in the development of cellular immunotherapies in […]
Syndax Pharmaceuticals Announces Appointment of Steve Sabus as Chief Commercial Officer
Syndax Pharmaceuticals, a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, has announced […]
AstraZeneca to Acquire Neogene Therapeutics, Accelerating Ambition in Oncology Cell Therapy
AstraZeneca has announced an agreement to acquire Neogene Therapeutics, a global clinical-stage biotechnology company pioneering […]
NHS Set to Eliminate Hepatitis C Ahead of Rest of the World
The NHS is on track to eliminate Hepatitis C by 2025 thanks to a pioneering […]
Liminatus Pharma and Iris Acquisition Corp to Combine to Incorporate and Accelerate Much-needed Cancer Treatments
Liminatus Pharma LLC, a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies and Iris Acquisition […]
COVID-19 Patients Show Liver Injury Months After Infection
COVID-19 infection is associated with increased liver stiffness, a sign of possible long-term liver injury, […]
BioStrand and BriaCell Announce Artificial Intelligence Collaboration and License Agreement to Discover and Develop Anti-Cancer Antibodies
IPA (Immunoprecise Antibodies), an advanced biotherapeutic research and technology company, today announced that BioStrand BV, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more